Register Now
Youtube Linkedin Facebook
dxpx logo white

Conference Experience

It’s time to get excited for the next big DxPx Conference in Munich, Germany!

Join us on October 5th for a day packed with fascinating industry insights, an exhibition of the most innovative startups, the 42PLUS1 Pitch Award, and countless one-to-one meetings.

We are looking forward to welcoming you at the next DxPx!

Speakers and moderators.

DxPx: Up Close.

DxPx is the only dedicated annual industry and investor partnering conference focusing on Diagnostics, Digital Health, Precision Medicine, and Life Science Tools. It is an established world series of partnering events and for the past four years now, we have been able to bring people together where our participants build long-lasting trustful partnerships with investors, industry leaders, startups, and accelerators.

benefits

Benefits of joining.

  • Schedule one-to-one meetings with relevant target groups, e.g., growth companies, investors, and decision makers.
  • Promote your innovation to industry leaders and showcase your products and/or services in person or virtually.
  • Learn from pioneers and disruptors of the industry and experience knowledge transfer at the highest level through our panel discussions and fireside chats.
  • Explore financing, licensing, and M&A opportunities.
  • Submit a pitch and have it reviewed by our executive jury. The best applicants will gain the opportunity to pitch their business and compete for $2,000,000 funding as convertibles at our 42PLUS1 Pitch Award (for startups!)
  • Be part of the DxPx EU Startup City where innovative startups and growth companies get their own booth and showcase their business.

One-to-one partnering and networking.

This is the heart and soul of DxPx.

Find your next collaborator through our professional digital partnering tool and preschedule your in-person one-to-one meetings in advance so you may discuss financing, co-development, licensing, and M&A opportunities seamlessly. Our improved digital partnering tool will select relevant partners for you via keywords, an AI-based algorythm and a smart search engine so you can use your time more efficiently and facilitate dealmaking.

At our conference venue, there are one-to-one meeting areas to hold your pre-scheduled business meetings in private and without distraction. Global networking made easy!

one-to-one-partnering-eu-2021

Want to support us?

Our conference is bringing together innovation players with investors.
Send us a message
DxPx EU

Date & Location:

On October 5, 2023, the DxPx Conference attracts startups and growth companies as well as established industry companies and investors to a diagnostics, digital health, precision medicine, and life science tools partnering conference at the Leonardo Royal Munich in Munich, Germany. Bringing together creative minds, visionaries, movers, decision-makers, and financiers, DxPx initiates dialogues. It’s not just any medical conference!

Plan your trip.

Travel and other information.

We are happy to welcome you to Munich, Germany! This dynamic city, serving as the capital of Bavaria, welcomes you with open arms and a wealth of experiences waiting to be embraced. Your visit to this captivating city promises to be nothing short of extraordinary, with a blend of rich history, modern flair, and special events.

Munich is celebrated for its historical significance and captivating architecture. The heart of the city, Marienplatz, beats with the rhythm of life, where the renowned New Town Hall (Neues Rathaus) stands tall, featuring the captivating Glockenspiel. As you immerse yourself in the city’s culture, you’ll find that Munich isn’t just a city; it’s an experience.

During your stay, make sure not to miss the exhilarating blend of the DxPx EU 2023 conference, taking place alongside Oktoberfest, the world’s largest beer festival. As you explore the bustling streets and charming alleyways, you’ll find that the festive spirit of Oktoberfest permeates every corner of the city. From the lively atmosphere of the beer tents to the aroma of traditional Bavarian cuisine, this event offers a unique and unforgettable cultural immersion. Amidst this merriment, the DxPx EU 2023 conference adds a touch of innovation, bringing together bright minds and industry leaders to explore the future of life sciences.

Don't miss our investor conferences & early-stage investing events:

dxpx us adlm logos
DxPx US

DxPx Industry & Investor Conference US:
4 Days In-Person

July 29 - Aug. 1, 2024
Chicago, IL
In the ADLM

Stay up to date and sign up for our latest news:

Next: DxPx U.S. 2025
  • 3 Days In-Person
  • July 29 - 31, 2025
  • McCormick Place
    Convention Center
    Chicago, Illinois, USA
Next: DxPx EU 2026
  • 2 Days In-Person
  • Reception: February 5, 2026
    Partnering Day & 42PLUS1:
    February 6, 2026
  • Munich, Germany
Download Brochure
DxPx media
Useful links

© Copyright DxPx 2025. All Rights Reserved.

Youtube Linkedin Facebook

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience